Aging is associated with an imbalance in sympathetic and parasympathetic outflow to cardiovascular effector organs. This autonomic imbalance contributes to the decline in cardiovagal baroreceptor ...

Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. Two new studies have been published that further focus attention on how the renin–angiotensin ...

Evidence suggests that virtually every organ system in the human body possesses a local renin–angiotensin system (RAS). These local systems seem to be independently regulated and compartmentalized ...

Forbes contributors publish independent expert analyses and insights. I'm a medical journalist covering cardiology news. The enormous success of ACE inhibitors in hypertension and heart failure ...

This is a preview. Log in through your library . Abstract Angiotensin II is the principle effector molecule of the renin angiotensin System (RAS). It exerts its various actions on the cardiovascular ...

Type 1 diabetes with CKD is understudied with no advancement of therapy options since the 1990s. The FINE-ONE phase 3 trial addresses a high, unmet need for treatments.

Recent cohort studies report that patients with coronavirus disease 2019 (COVID-19) and hypertension or diabetes have an increased risk of respiratory failure and death; such patients are often ...

In a recent study posted to the medRxiv* preprint server, researchers conducted an umbrella review and meta-analysis of the renin-angiotensin-aldosterone system (RAAS) inhibitors' impact on ...

[Updated]-- The European Medicines Agency said last week that it was initiating a review of the combined use of agents that block the renin-angiotensin system (RAS). The three classes of RAS-blocking ...

Introduction: The expression of glucagon-like peptide receptors (GLP-Rs) in epicardial fat (EF) and pericardial fat (PF) depots might be involved in the pathogenesis of cardiovascular diseases.